ARS Pharmaceuticals, Inc. (SPRY)
9.01
-0.43
(-4.56%)
USD |
NASDAQ |
Feb 20, 16:00
9.05
+0.04
(+0.44%)
After-Hours: 18:20
ARS Pharmaceuticals EPS Diluted (Quarterly) : -0.5177 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -51.15M |
| Revenue (Quarterly) | 32.50M |
| Total Expenses (Quarterly) | 83.65M |
| Enterprise Value | 742.68M |
| Gross Profit Margin (Quarterly) | 74.80% |
| Profit Margin (Quarterly) | -157.4% |
| Earnings Yield | -8.99% |
| Normalized Earnings Yield | -8.993 |